Vantage Investment Advisors’s VivoSim Labs VIVS Stock Holding History

Vantage Investment Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-36	Closed	-$32K	–	854
2016 Q2	$32K	Buy	36 +8	+29%	+$5.37K	0.01%	330
2016 Q1	$14K	Hold	28	–	–	0.01%	466
2015 Q4	$17K	Hold	28	–	–	0.01%	421
2015 Q3	$18K	Hold	28	–	–	0.01%	403
2015 Q2	$25K	Sell	28 -27	-49%	-$30.2K	0.01%	342
2015 Q1	$47K	Buy	55 +23	+72%	+$31.8K	0.01%	351
2014 Q4	$56K	Hold	32	–	–	0.03%	230
2014 Q3	$49K	Hold	32	–	–	0.03%	230
2014 Q2	$65K	Buy	32 +1	+3%	+$1.68K	0.04%	205
2014 Q1	$57K	Hold	31	–	–	0.04%	201
2013 Q4	$82K	Buy	+31	New	+$60.9K	0.06%	172

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Vantage Investment Advisors's VIVS Position: Q3 2016 in Review

Vantage Investment Advisors sold out of VivoSim Labs (VIVS) in Q3 2016, closing a stake of 36 shares — an estimated $32K sold.

Vantage Investment Advisors first reported a position in VIVS in Q4 2013 and held it in 11 quarters. The position peaked at $82K in Q4 2013. 122 funds tracked by Wall St. Rank hold VIVS as of Q3 2016.

Vantage Investment Advisors reported no remaining VivoSim Labs position as of Q3 2016 after selling out during the quarter.
Vantage Investment Advisors sold 36 VivoSim Labs shares in Q3 2016, an estimated $32K.
Vantage Investment Advisors first reported a position in VivoSim Labs in Q4 2013 and held it in 11 quarters.
Vantage Investment Advisors's VivoSim Labs position peaked at $82K in Q4 2013.
122 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2016.

Based on Vantage Investment Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.